BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2274372)

  • 1. [Advances in the biology of multiple myeloma].
    Klein B; Bataille R
    Pathol Biol (Paris); 1990 Oct; 38(8):820-1. PubMed ID: 2274372
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
    Allione A; Consalvo M; Nanni P; Lollini PL; Cavallo F; Giovarelli M; Forni M; Gulino A; Colombo MP; Dellabona P
    Cancer Res; 1994 Dec; 54(23):6022-6. PubMed ID: 7954438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
    Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
    Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins.
    Taupin V; Gogusev J; Descamps-Latscha B; Zavala F
    Mol Pharmacol; 1993 Jan; 43(1):64-9. PubMed ID: 8380885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
    Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
    Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
    Jacobsen SE; Ruscetti FW; Ortiz M; Gooya JM; Keller JR
    Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular human T cell leukemia virus type I tax protein stimulates the proliferation of human synovial cells.
    Aono H; Fujisawa K; Hasunuma T; Marriott SJ; Nishioka K
    Arthritis Rheum; 1998 Nov; 41(11):1995-2003. PubMed ID: 9811055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
    Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of cytokines in the regulation of HIV expression].
    Molina JM
    Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):777-80. PubMed ID: 8309720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro.
    Trindade MC; Nakashima Y; Lind M; Sun DH; Goodman SB; Maloney WJ; Schurman DJ; Smith RL
    J Orthop Res; 1999 Nov; 17(6):797-802. PubMed ID: 10632444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth factors in multiple myeloma].
    Klein B; Bataille R
    Presse Med; 1990 Dec; 19(43):1972-3. PubMed ID: 2149597
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematopoietic growth factors stimulate paraprotein isotype production by bone marrow mononuclear cells in an aggressive case of multiple myeloma.
    Säily M; Koistinen P; Laine S; Soppi E; Savolainen ER
    J Clin Lab Immunol; 1995; 46(1):41-7. PubMed ID: 9363591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of hematopoietic growth factors on human breast epithelial cell growth in serum-free primary culture.
    Emerman JT; Eaves CJ
    Bone Marrow Transplant; 1994 Mar; 13(3):285-91. PubMed ID: 7515301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements.
    Stoecklin G; Stoeckle P; Lu M; Muehlemann O; Moroni C
    RNA; 2001 Nov; 7(11):1578-88. PubMed ID: 11720287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
    Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
    Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.